WaveMan · Form 4
Bradsher Neal C insider trades
> Search tickers & screens ⌘K
LIVE

Bradsher Neal C insider trades

Bradsher Neal C has filed 22 Form 4s with the SEC that we hold, for Staar Surgical Co (STAA) (Director, 10% owner), Lineage Cell Therapeutics, Inc. (LCTX) (Director, 10% owner) and Insight Molecular Diagnostics Inc. (IMDX) (10% owner). Across all of them we count 39 purchases worth $96.0M and 0 sales worth $0 reported on Form 4. In the last 12 months: 9 purchases ($53.5M) and 0 sales ($0). The largest single trade was a purchase of 797,486 shares of Staar Surgical Co worth $22.2M, dated 2025-11-21. The first filing on our record is dated 2021-07-01 and the latest 2026-07-02.

Staar Surgical Co (STAA)

Director, 10% owner · 14 filings · 35 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-09-05P, purchase reported on Form 420,144$843.4K2023-09-07
2023-09-06P, purchase reported on Form 4108,944$4.5M2023-09-07
2023-09-07P, purchase reported on Form 460,874$2.5M2023-09-07
2023-11-02P, purchase reported on Form 487,849$3.1M2023-11-06
2023-11-02P, purchase reported on Form 456,178$2.0M2023-11-06
2023-11-03P, purchase reported on Form 4520$18.8K2023-11-06
2023-11-06P, purchase reported on Form 4164,607$5.6M2023-11-06
2023-11-07P, purchase reported on Form 49,731$331.1K2023-11-09
2023-11-08P, purchase reported on Form 4139,409$4.7M2023-11-09
2023-11-09P, purchase reported on Form 4119,390$3.9M2023-11-09
2023-11-09P, purchase reported on Form 420,610$693.3K2023-11-09
2023-11-10P, purchase reported on Form 434,320$1.1M2023-11-14
2023-11-13P, purchase reported on Form 4507$16.8K2023-11-14
2025-01-14P, purchase reported on Form 421,155$454.0K2025-01-16
2025-01-16P, purchase reported on Form 48,221$176.8K2025-01-16
2025-02-12P, purchase reported on Form 472,017$1.1M2025-02-14
2025-02-12P, purchase reported on Form 482,730$1.2M2025-02-14
2025-02-12P, purchase reported on Form 4104,869$1.7M2025-02-14
2025-02-13P, purchase reported on Form 4115,282$1.8M2025-02-14
2025-02-14P, purchase reported on Form 436,532$565.9K2025-02-14
2025-03-26P, purchase reported on Form 4101,633$1.8M2025-03-28
2025-03-27P, purchase reported on Form 43,620$63.3K2025-03-28
2025-03-28P, purchase reported on Form 48,131$142.0K2025-03-28
2025-04-08P, purchase reported on Form 411,600$185.0K2025-04-10
2025-04-08P, purchase reported on Form 4166,527$2.5M2025-04-10
2025-04-09P, purchase reported on Form 48,200$123.7K2025-04-10
2025-04-10P, purchase reported on Form 4900$13.7K2025-04-10
2025-11-19P, purchase reported on Form 4309,132$8.2M2025-11-21
2025-11-20P, purchase reported on Form 4393,382$10.7M2025-11-21
2025-11-21P, purchase reported on Form 4797,486$22.2M2025-11-21
2026-01-06P, purchase reported on Form 4150,000$3.4M2026-01-08
2026-01-06P, purchase reported on Form 4186,946$3.9M2026-01-08
2026-01-07P, purchase reported on Form 466,467$1.5M2026-01-08
2026-01-08P, purchase reported on Form 43,240$71.1K2026-01-08
2026-01-09P, purchase reported on Form 427,485$606.0K2026-01-13

Lineage Cell Therapeutics, Inc. (LCTX)

Director, 10% owner · 7 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-03-23P, purchase reported on Form 4260,106$356.3K2022-03-25
2022-03-24P, purchase reported on Form 4200,000$284.0K2022-03-25
2022-03-25P, purchase reported on Form 4470,000$676.8K2022-03-25

Insight Molecular Diagnostics Inc. (IMDX)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-02-10P, purchase reported on Form 4521,739$3.0M2026-02-12
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1278388) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms